AN2 Therapeutics, Inc.
Nasdaq · CIK 0001880438 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | AN2 Therapeutics, Inc. | 2026-07-10 | 0001193125-26-301167 |
| 4 | AN2 Therapeutics, Inc. | 2026-07-10 | 0001193125-26-301166 |
| 4 | AN2 Therapeutics, Inc. | 2026-07-10 | 0001193125-26-301165 |
| 4 | AN2 Therapeutics, Inc. | 2026-07-10 | 0001193125-26-301092 |
| 4 | AN2 Therapeutics, Inc. | 2026-06-02 | 0001193125-26-253622 |
| 10-Q | AN2 Therapeutics, Inc. | 2026-05-11 | 0001193125-26-216755 |
| 4 | AN2 Therapeutics, Inc. | 2026-04-10 | 0001193125-26-151632 |
| 4 | AN2 Therapeutics, Inc. | 2026-04-10 | 0001193125-26-151628 |
| 4 | AN2 Therapeutics, Inc. | 2026-04-10 | 0001193125-26-151626 |
| 10-K | AN2 Therapeutics, Inc. | 2026-03-17 | 0001193125-26-110693 |
| 4 | AN2 Therapeutics, Inc. | 2026-03-05 | 0001193125-26-094490 |
| 4 | AN2 Therapeutics, Inc. | 2026-02-23 | 0001193125-26-064174 |
| 4 | AN2 Therapeutics, Inc. | 2026-02-23 | 0001193125-26-064166 |
| 4 | AN2 Therapeutics, Inc. | 2026-02-23 | 0001193125-26-064151 |
| 4 | AN2 Therapeutics, Inc. | 2026-02-23 | 0001193125-26-064141 |
| 4 | AN2 Therapeutics, Inc. | 2026-02-23 | 0001193125-26-064176 |
| 4 | AN2 Therapeutics, Inc. | 2026-01-14 | 0001193125-26-013035 |
| 4 | AN2 Therapeutics, Inc. | 2026-01-14 | 0001193125-26-013041 |
| 4 | AN2 Therapeutics, Inc. | 2026-01-14 | 0001193125-26-013038 |
| 4 | AN2 Therapeutics, Inc. | 2026-01-07 | 0001193125-26-006771 |
| 4 | AN2 Therapeutics, Inc. | 2026-01-07 | 0001193125-26-006770 |
| 4 | AN2 Therapeutics, Inc. | 2026-01-07 | 0001193125-26-006765 |
| 4 | AN2 Therapeutics, Inc. | 2026-01-07 | 0001193125-26-006763 |
| 10-Q | AN2 Therapeutics, Inc. | 2025-11-12 | 0001193125-25-277673 |
| 4 | AN2 Therapeutics, Inc. | 2025-11-06 | 0001193125-25-270255 |
| 4 | AN2 Therapeutics, Inc. | 2025-11-06 | 0001193125-25-270252 |
| 4 | AN2 Therapeutics, Inc. | 2025-10-14 | 0001193125-25-238984 |
| 4 | AN2 Therapeutics, Inc. | 2025-10-14 | 0001193125-25-238983 |
| 4 | AN2 Therapeutics, Inc. | 2025-10-14 | 0001193125-25-238982 |
| 10-Q | AN2 Therapeutics, Inc. | 2025-08-12 | 0000950170-25-107301 |